IN2014MU00495A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00495A IN2014MU00495A IN495MU2014A IN2014MU00495A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A IN 495MU2014 A IN495MU2014 A IN 495MU2014A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutical compositions
- abstract
- cancer
- preparing
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 abstract 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2015/050384 WO2015121649A1 (en) | 2014-02-12 | 2015-02-12 | Pharmaceutical composition comprising vemurafenib |
| IN495MU2014 IN2014MU00495A (enrdf_load_html_response) | 2014-02-12 | 2015-02-12 | |
| ZA2015/00995A ZA201500995B (en) | 2014-02-12 | 2015-02-12 | Low dose pharmaceutical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN495MU2014 IN2014MU00495A (enrdf_load_html_response) | 2014-02-12 | 2015-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00495A true IN2014MU00495A (enrdf_load_html_response) | 2015-09-25 |
Family
ID=52544516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN495MU2014 IN2014MU00495A (enrdf_load_html_response) | 2014-02-12 | 2015-02-12 |
Country Status (3)
| Country | Link |
|---|---|
| IN (1) | IN2014MU00495A (enrdf_load_html_response) |
| WO (1) | WO2015121649A1 (enrdf_load_html_response) |
| ZA (1) | ZA201500995B (enrdf_load_html_response) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| CA3068936A1 (en) * | 2017-07-05 | 2019-01-10 | Novartis Ag | Novel pharmaceutical composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110269838A (zh) * | 2009-04-03 | 2019-09-24 | 豪夫迈罗氏公司 | 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途 |
| US20130172375A1 (en) * | 2011-12-13 | 2013-07-04 | Hoffmann-La Roche Inc. | Pharmaceutical composition |
-
2015
- 2015-02-12 IN IN495MU2014 patent/IN2014MU00495A/en unknown
- 2015-02-12 WO PCT/GB2015/050384 patent/WO2015121649A1/en active Application Filing
- 2015-02-12 ZA ZA2015/00995A patent/ZA201500995B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015121649A1 (en) | 2015-08-20 |
| ZA201500995B (en) | 2015-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004557B (en) | Modulatory polynucleotides | |
| PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
| MX2020012165A (es) | Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer. | |
| PH12016501898B1 (en) | Quinoxaline derivatives useful as fgfr kinase modulators | |
| ZA201605715B (en) | Cyclopropylamines as lsd1 inhibitors | |
| PH12016501601A1 (en) | Cyclopropylamines as lsd1 inhibitors | |
| MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
| PH12016500330B1 (en) | Certain chemical entities, compositions, and methods | |
| TW201613860A (en) | Cyclopropylamines as LSD1 inhibitors | |
| TW201613886A (en) | 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones | |
| IN2014MU00303A (enrdf_load_html_response) | ||
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| PH12017500853B1 (en) | Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases | |
| IN2014CH00840A (enrdf_load_html_response) | ||
| HK1254231A1 (zh) | 米托-和厚朴酚化合物及其合成方法和用途 | |
| IN2014MU00916A (enrdf_load_html_response) | ||
| GEP201706795B (en) | Hexahydrofuropyrroles as pde1 inhibitors | |
| IN2014MU00495A (enrdf_load_html_response) | ||
| PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
| EA201691620A1 (ru) | Циклопропиламины в качестве ингибиторов lsd1 | |
| MY182434A (en) | Certain chemical entities, compositions, and methods |